Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 11;11(6):546.
doi: 10.3390/jpm11060546.

The Female Reproductive Tract Microbiome-Implications for Gynecologic Cancers and Personalized Medicine

Affiliations
Free PMC article
Review

The Female Reproductive Tract Microbiome-Implications for Gynecologic Cancers and Personalized Medicine

Anthony E Rizzo et al. J Pers Med. .
Free PMC article

Abstract

The microbial colonization of the lower female reproductive tract has been extensively studied over the past few decades. In contrast, the upper female reproductive tract including the uterine cavity and peritoneum where the ovaries and fallopian tubes reside were traditionally assumed to be sterile under non-pathologic conditions. However, recent studies applying next-generation sequencing of the bacterial 16S ribosomal RNA gene have provided convincing evidence for the existence of an upper female reproductive tract microbiome. While the vaginal microbiome and its importance for reproductive health outcomes has been extensively studied, the microbiome of the upper female reproductive tract and its relevance for gynecologic cancers has been less studied and will be the focus of this article. This targeted review summarizes the pertinent literature on the female reproductive tract microbiome in gynecologic malignancies and its anticipated role in future research and clinical applications in personalized medicine.

Keywords: endometrial cancer; female reproductive tract microbiome; gynecologic cancer; ovarian cancer; upper reproductive tract microbiome; uterine microbiome; vaginal microbiome.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Turnbaugh P.J., Ley R.E., Hamady M., Fraser-Liggett C.M., Knight R., Gordon J.I. The Human Microbiome Project. Nature. 2007;449:804–810. doi: 10.1038/nature06244. - DOI - PMC - PubMed
    1. Integrative HMP (iHMP) Research Network Consortium The Integrative Human Microbiome Project: Dynamic Analysis of Microbiome-Host Omics Profiles during Periods of Human Health and Disease. Cell Host Microbe. 2014;16:276–289. doi: 10.1016/j.chom.2014.08.014. - DOI - PMC - PubMed
    1. Chow J., Lee S.M., Shen Y., Khosravi A., Mazmanian S.K. Host–Bacterial Symbiosis in Health and Disease. Adv. Immunol. 2010;107:243–274. doi: 10.1016/b978-0-12-381300-8.00008-3. - DOI - PMC - PubMed
    1. Vétizou M., Pitt J.M., Daillère R., Lepage P., Waldschmitt N., Flament C., Rusakiewicz S., Routy B., Roberti M.P., Duong C.P.M., et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350:1079–1084. doi: 10.1126/science.aad1329. - DOI - PMC - PubMed
    1. Gopalakrishnan V., Spencer C.N., Nezi L., Reuben A., Andrews M.C., Karpinets T.V., Prieto P.A., Vicente D., Hoffman K., Wei S.C., et al. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients. Science. 2018;359:97–103. doi: 10.1126/science.aan4236. - DOI - PMC - PubMed

LinkOut - more resources